Model
Edge
Janux Therapeutics
0001863094
Filing Type
4
Filing Date
6/12/2025
Updated
6/13/25, 5:30 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership